Prospects of Treating Prostate Cancer through Apalutamide: A Mini-Review
Volume: 22, Issue: 6, Pages: 1056 - 1067
Published: Apr 1, 2022
Abstract
Prostate cancer is considered the second most diagnosed cancer, and one of the most common causes of death from cancer in men. Apalutamide is an effective, safe, and well-tolerated agent used for the treatment of men with non-metastatic Castration-Resistant Prostate Cancer (nmCRPC) and metastatic Hormone-Naive Prostate Cancer (mHNPC). Androgen receptor signaling is a leading factor that drives these prostate tumors. USFDA has approved...
Paper Details
Title
Prospects of Treating Prostate Cancer through Apalutamide: A Mini-Review
Published Date
Apr 1, 2022
Volume
22
Issue
6
Pages
1056 - 1067
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History